What is EMERGE?
Following the 2016 PReS YIM in Genoa, a new group of young paediatric rheumatologists and researchers was founded called PReS EMERGE (EMErging RheumatoloGists and rEsearchers). The overarching aim of the group is to improve clinical and research opportunities for trainees from all over the world working in the field of paediatric rheumatology. The group is currently working on a number of initiatives, with the first to be implemented being the PReS EMERGE Fellowship program.
What is the PReS EMERGE Fellowship program?
This program provides financial and practical assistance for paediatric rheumatology trainees who are members of PReS and younger than 45 years, to facilitate placements of up to 6-months within a European Paediatric Rheumatology Centre. In addition to gaining clinical knowledge and skills, the trainee will be given the opportunity to participate in a research project.
The overall aims of this initiative are to:
- Enhance both clinical and basic collaborative research conducted by trainees within Europe
- Foster a network of emerging and established paediatric rheumatologists
- Allow sharing of ideas and practices between different countries to harmonize paediatric rheumatology training and stimulate collaboration in the field
How to apply?
The first application deadline is 1st of September 2017. To apply the trainee is asked to propose a paediatric rheumatology training centre which can provide opportunities complementary to those of their main training site. The chosen centre will help the trainee to attain additional specialist clinical/research knowledge and skills. The trainee is required to take the initiative on the application but can work closely with the centre of interest to develop a relevant, realistic and achievable plan for her/his placement.
Each candidate will be asked to complete a standardised paediatric rheumatology trainee questionnaire which will allow assessment of the candidates suitability. In addition to the questionnaires the trainee will supply (1) a short CV (2) a concise and clear outline of the research project to be undertaken (3) a personal statement supporting the application (4) a statement of the training center willing to accept the applicant.
All documents or inquiries should be sent to firstname.lastname@example.org. Further information on the program is attached to this newsletter.
Can I join EMERGE?
The PRES EMERGE group is still growing and welcomes new members. To join please e-mail email@example.com providing details of your training centre, your current position and function, and any particular areas of interest that you have. You can also find further information and follow EMERGE on Facebook (www.facebook.com/PReSEMERGE) and Twitter (@PRESEMERGE).
PROGRAM PURPOSE IS TO:
- Provide opportunities of in-depth clinical and research training for young physicians/scientists in the field of Pediatric Rheumatology
- Foster development of a network of emerging and established paediatric rheumatologists;
- Improve the care for children with rheumatic diseases in Europe following cross fertilization of ideas and practices;
- Enhance both clinical and basic collaborative research in the field of the paediatric rheumatology, improving the contribution of Europe to international scientific progress in the field of paediatric rheumatology.
- This program is aimed at paediatric rheumatology trainees who are members of PReS and younger than 45 years, allowing them to visit a Paediatric Rheumatology Centre within Europe for the period of up to 6 months.
- The program has both clinical and research components. In addition to gaining clinical knowledge and skills, the trainee will be given the opportunity to participate in a research project during their six-month placement, which they may continue after ending the fellowship. A brief outline of the intended project will be required as part of the fellowship application. It is envisaged that the trainee would liaise with the centre where they intend to complete the placement to identify a relevant, realistic and achievable project plan.
- The fellowship program will be co-ordinated and applications reviewed by two appointed members of the EMERGE group, two members of the PRES council and one external PRES member.
- The program will be announced to all PRES members three months prior to application deadline. It will be advertised in the PRES newsletter which is sent to all PRES members by e-mail. Additional information will also be available on the PRES website and EMERGE social media platforms (Facebook, Twitter).
- The application deadline will be twice a year (first is 1st September 2017, 2nd will be in spring 2018).
- To start with there will be one fellowship available at each application deadline, but this will be reviewed in the future depending upon the success of the programme and the financial capabilities of the PRES society.
- Prior to application, each candidate will be expected to contact the Paediatric Rheumatology Centre of interest (within Europe) to discuss and plan both the clinical and research components of their fellowship. The EMERGE group can provide advice for candidates who need information about the different European Paediatric Rheumatology Training Centres.
- The training centre will have to comply with the European Syllabus requirements for training centers in Pediatric Rheumatology. The members of the PRES council reviewing the application will confirm the suitability of the center.
- Each candidate also has to complete a detailed trainee questionnaire so the suitability of the candidate can be assessed by the fellowship programme co-ordinators (see appendix 1).
- The candidates, if more than one, will be judged by the programme coordinators, based on the application form. If a member of the coordinating team has a potential conflict of interest in a particular application, she/he will not participate in the judging of that application.
- The selected candidate will be announced within two weeks of the application deadline.
- If the candidate chosen for the fellowship cannot take up their place in the programme, the next candidate on the list will be considered.
- The candidate and Paediatric Rheumatology Training Centre contact person will then arrange all the details of the fellowship, with support from the EMERGE group where necessary.
- Each candidate undertaking the fellowship is expected to submit a mid (after three months) and end (after six months) fellowship report. In the mid-term report, the candidate should detail their progress towards meeting the objectives detailed in their fellowship application. This report will be assessed by the program coordinators and if progress is deemed not to be satisfactory, then the fellowship support could be withdrawn. The end of fellowship report should be more detailed and cover the process they went through to embark on their fellowship (any need for medical council registration, vaccinations, occupational health checks, finding accommodation, language issues etc), a summary report of what the placement involved and what they gained from it (modules and learning outcomes attained, clinics attended, summary of number of cases seen), the results and any outputs from their fellowship research project (presentations, published abstracts/papers, grant applications pending, further work anticipated, collaborations established etc). These reports will be available to future trainees who are applying for the fellowship. A summary of their experience may also be used in EMERGE newsletters and other social media platforms
Each bursary includes 1,000 euro for travel assistance and 1000 euro per month for living expenses (max 7,000 euro total per candidate).
PROGRAM DEADLINES (for 2017):
Program will be announced in May/June 2017
Application deadline will be 1st of September 2017
Selected candidates would be announced at PRES congress in Athens (14th of September)
The fellowship should begin between October-December 2017
Prof Carine Wouters (PRES council)
Prof Rolando Cimaz (PRES council)
Lovro Lamot (EMERGE group)
Eve Smith (EMERGE group)
Prof Lucy Wedderburn (external PRES member)